title: [The precision surgical treatment strategies of lung adenocarcinoma under the guidance of the WHO new classification].
abstract: The 2015 WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published recently. In this newly classification, WHO almost completely accepted the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. A lot of high-quality studies in the past five years have demonstrated important guiding significance of the newly classification in surgical treatment of adenocarcinoma. Surgeons should consider not only the tumor size but also the biological behavior of different subtypes of adenocarcinomas. For adjuvant chemotherapy, more aggressive subtypes of adenocarcinomas may have more survival benefit. Different biological behavior of different subtypes of adenocarcinomas also need different follow-up strategies. The precision surgical treatment strategies of lung adenocarcinoma under the guidance of the WHO new classification is discussed in this paper.
authors.affiliation: Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
authors.forename: F
authors.initials: F
authors.lastname: Yang
authors.forename: H
authors.initials: H
authors.lastname: Li
authors.forename: J
authors.initials: J
authors.lastname: Wang
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery*; D000077192:Adenocarcinoma of Lung; D017024:Chemotherapy, Adjuvant; D017408:Guidelines as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery*